Change of Nominated Adviser and Joint Broker

RNS Number : 2825M
Challenger Energy Group PLC
11 January 2023
 

11 January 2023

 

Challenger Energy Group Plc

("Challenger Energy" or the "Company")

 

Change of Nominated Adviser and Joint Broker

 

Challenger Energy (AIM: CEG), the  Caribbean  and  Americas focused oil and gas company, with oil production, appraisal, development and exploration assets across the region, is pleased to announce that it has appointed WH Ireland Limited as the Company's Nominated Adviser and Joint Broker with immediate effect.

Arden Partners plc remains as Joint Broker to the Company.

 

For further information, please contact:

 

Challenger Energy Group Plc

Eytan Uliel, Chief Executive Officer

Tel: +44 (0) 1624 647 882

WH Ireland Limited - Nomad & Joint Broker

Antonio Bossi / Enzo Aliaj

Tel: +44 (0) 20 7220 1666

Arden Partners plc - Joint Broker

Simon Johnson

Tel: +44 (0) 20 7614 5900

 

CAMARCO

Billy Clegg / Hugo Liddy / Sam Morris

 Tel: +44 (0) 20 3757 4980

 

Notes to Editors

 

Challenger Energy is a Caribbean and Americas focused oil and gas company, with a range of  exploration, appraisal, development and production assets and licences, located onshore in Trinidad and Tobago, and Suriname, and offshore in the waters of Uruguay and The Bahamas. In Trinidad and Tobago, Challenger Energy has five (5) producing fields, two (2) appraisal / development projects and a prospective exploration portfolio in the South West Peninsula. In Suriname, Challenger Energy has on onshore appraisal / development project. Challenger Energy's exploration licences in Uruguay, the South West Peninsula of Trinidad, and The Bahamas offer high-impact value exposure within the overall portfolio value.

 

Challenger Energy is quoted on the AIM market of the London Stock Exchange. 

 

https://www.cegplc.com  

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPURSOROAUAAAR
UK 100

Latest directors dealings